期刊的影响因子--文章列表

期刊文章列表
Yau-tuen Chan¹，Hor-yue Tan^1,2，Yuanjun Lu¹，Cheng Zhang¹，Chien-shan Cheng^1,3，Junyu Wu¹，Ning Wang¹，Yibin Feng¹（School of Chinese Medicine，the University of Hong Kong；Centre for Chinese Herbal Medicine Drug Development，School of Chinese Medicine，Hong Kong Baptist University；Department of Traditional Chinese Medicine，Shanghai Jiaotong University，School of Medicine Affiliated Ruijin Hospital）.Pancreatic melatonin enhances anti-tumor immunity in pancreatic adenocarcinoma through regulating tumor-associated neutrophils infiltration and NETosis[J].Acta Pharmaceutica Sinica B,2023,第4期 Xiaoxi Lv¹，Shanshan Liu²，Chang Liu，Yunxuan Li⁴，Tingting Zhang⁴，Jie Qi⁵，Ke Li⁴，Fang Hua¹，Bing Cui¹，Xiaowei Zhang¹，Yuxin Liu¹，Jiaojiao Yu¹，Jinmei Yu¹，Li Li¹，Xia Li⁵，Zhigang Yao⁶，Bo Huang⁷（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences & Peking Union Medical College；National Clinical Research Center for Metabolic Diseases，Key Laboratory of Diabetes Immunology，Ministry of Education，And Department of Metabolism and Endocrinology，The Second Xiangya Hospital of Central South University；Drug Clinical Trial Institution，Children’s Hospital，Capital Institute of Pediatrics；Institute of Medicinal Biotechnology，Chinese Academy of Medical Sciences & Peking Union Medical College；Shandong University；Department of Respiratory Medicine，Beijing Friendship Hospital，Capital Medical University；Institute of Basic Medicine，Chinese Academy of Medical Sciences & Peking Union Medical College）.TRIB3 promotes pulmonary fibrosis through inhibiting SLUG degradation by physically interacting with MDM2[J].Acta Pharmaceutica Sinica B,2023,第4期 Kamila Butowska^1,2，Xuexiang Han¹，Ningqiang Gong¹，Rakan El-Mayta¹，Rebecca M.Haley¹，Lulu Xue¹，Wenqun Zhong³，Wei Guo³，Karin Wang⁴，Michael J.Mitchell^1,5,6,7,8（Department of Bioengineering，University of Pennsylvania；Intercollegiate Faculty of Biotechnology，University of Gda nsk & Medical University of Gda nsk；Department of Biology，University of Pennsylvania；Department of Bioengineering，Temple University；Abramson Cancer Center，Perelman School of Medicine，University of Pennsylvania；Institute for Immunology，Perelman School of Medicine，University of Pennsylvania；Cardiovascular Institute，Perelman School of Medicine，University of Pennsylvania；Institute for Regenerative Medicine，Perelman School of Medicine，University of Pennsylvania）.Doxorubicin-conjugated siRNA lipid nanoparticles for combination cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第4期 Zi-Han Ye¹，Wei-Bang Yu¹，Mu-Yang Huang¹，Jun Chen²，Jin-Jian Lu^1,3,4,5（State Key Laboratory of Quality Research in Chinese Medicine，Institute of Chinese Medical Sciences，University of Macau；Zhongshan School of Medicine，Sun Yat-sen University；Department of Pharmaceutical Sciences，Faculty of Health Sciences，University of Macau；MoE Frontiers Science Center for Precision Oncology，University of Macau；Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research，University of Macau）.Building on the backbone of CD47-based therapy in cancer：Combination strategies, mechanisms, and future perspectives[J].Acta Pharmaceutica Sinica B,2023,第4期 Nasir Uddin^1,2,3，Daniel W.Binzel^1,2,3，Dan Shu^1,2,3，Tian-Min Fu⁴，Peixuan Guo^1,2,3（Center for RNA Nanobiotechnology and Nanomedicine，Division of Pharmaceutics and Pharmacology，College of Pharmacy，the Ohio State University；Dorothy M.Davis Heart and Lung Research Institute，the Ohio State University；James Comprehensive Cancer Center，College of Medicine，the Ohio State University；Department of Biological Chemistry & Pharmacology，College of Medicine，the Ohio State University）.Targeted delivery of RNAi to cancer cells using RNA-ligand displaying exosome[J].Acta Pharmaceutica Sinica B,2023,第4期 Dan Gao¹，Sajid Asghar²，Rongfeng Hu³，Su Chen¹，Ruixin Niu¹，Jia Liu⁴，Zhipeng Chen⁵，Yanyu Xiao¹（State Key Laboratory of Natural Medicines，China Pharmaceutical University；Faculty of Pharmaceutical Sciences，Government College University Faisalabad；Anhui Province Key Laboratory of Pharmaceutical Preparation Technology and Application；Jiangyin Hospital Affiliated to Nanjing University of Chinese Medicine；Department of Pharmacy，Nanjing University of Chinese Medicine）.Recent advances in diverse nanosystems for nitric oxide delivery in cancer therapy[J].Acta Pharmaceutica Sinica B,2023,第4期 Yixiang Xu¹，Chao Zhang¹，Kai Jiang²，Xinchun Yang³，Feng Chen²，Zhiyang Cheng²，Jinlong Zhao³，Jiaxing Cheng³，Xiaokang Li¹，Xin Chen¹，Luoyifan Zhou¹，Hao Duan¹，Yunyuan Huang⁴，Yaozu Xiang²，Jian Li^1,5,6,7（State Key Laboratory of Bioreactor Engineering，Shanghai Frontiers Science Center of Optogenetic Techniques for Cell Metabolism，Frontiers Science Center for Materiobiology and Dynamic Chemistry，Shanghai Key Laboratory of New Drug Design，School of Pharmacy，East China University of Science and Technology；Shanghai East Hospital，School of Life Sciences and Technology，Tongji University；East China University of Science and Technology-Tengbai Pharmaceutical Innovative Drugs Joint Research Institute，Zhuhai Tengbai Pharmaceutical Co.，Ltd.；Hubei Key Laboratory of Genetic Regulation and Integrative Biology，School of Life Sciences，Central China Normal University；Yunnan Key Laboratory of Screening and Research on Anti-pathogenic Plant Resources from West Yunnan，College of Pharmacy，Dali University；Clinical Medicine Scientific and Technical Innovation Center，Shanghai Tenth People's Hospital，Tongji University School of Medicine；Key Laboratory of Tropical Biological Resources of Ministry of Education，College of Pharmacy，Hainan University）.Structural repurposing of SGLT2 inhibitor empagliflozin for strengthening anti-heart failure activity with lower glycosuria[J].Acta Pharmaceutica Sinica B,2023,第4期 Yan Shi¹，Candy Lee²，Peng Sang¹，Zaid Amso²，David Huang²，Weixia Zhong²，Meng Gu¹，Lulu Wei¹，Van T.B.Nguyen-Tran²，Jingyao Zhang¹，Weijun Shen²，Jianfeng Cai¹（Department of Chemistry，University of South Florida；Calibr at Scripps Research）.α/Sulfono-γ-AA peptide hybrids agonist of GLP-1R with prolonged action both in vitro and in vivo[J].Acta Pharmaceutica Sinica B,2023,第4期 Xiaoqing Liu，Shuang Liang，Xiao Sang，Lili Chang，Shunli Fu，Han Yang，Huizhen Yang，Yongjun Liu，Na Zhang（Department of Pharmaceutics，Key Laboratory of Chemical Biology（Ministry of Education），NMPA Key Laboratory for Technology Research and Evaluation of Drug Products，School of Pharmaceutical Sciences，Cheeloo College of Medicine，Shandong University）.On-demand integrated nano-engager converting cold tumors to hot via increased DNA damage and dual immune checkpoint inhibition[J].Acta Pharmaceutica Sinica B,2023,第4期 Xuan Li¹，Shicheng Fan^1,2，Chenghui Cai¹，Yue Gao¹，Xinhui Wang³，Yifei Zhang¹，Hangfei Liang¹，Huilin Li¹，Jie Yang¹，Min Huang¹，Huichang Bi^1,2（Guangdong Provincial Key Laboratory of New Drug Design and Evaluation，School of Pharmaceutical Sciences，Sun Yat-sen University；NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening，School of Pharmaceutical Sciences，Southern Medical University；School of Pharmaceutical Sciences(Shenzhen)，Sun Yat-sen University）.YAP regulates the liver size during the fasting-refeeding transition in mice[J].Acta Pharmaceutica Sinica B,2023,第4期 Yiwei Zhu，Lin Lei，Xinghui Wang，Linfang Chen，Wei Li，Jinxia Li，Chenchen Zhao，Xiliang Du，Yuxiang Song，Wenwen Gao，Guowen Liu，Xinwei Li（State Key Laboratory for Zoonotic Diseases，Key Laboratory of Zoonosis Research，Ministry of Education，College of Veterinary Medicine，Jilin University）.The E3 ubiquitin ligase NEDD4-1 protects against acetaminophen-induced liver injury by targeting VDAC1 for degradation[J].Acta Pharmaceutica Sinica B,2023,第4期 Mingming Zheng¹，Wenxin Zhang¹，Xi Chen¹，Hongjie Guo¹，Honghai Wu¹，Yanjun Xu²，Qiaojun He^1,3,4，Ling Ding¹，Bo Yang^1,3（Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，Institute of Pharmacology and Toxicology，College of Pharmaceutical Sciences，Zhejiang University；Department of Medical Thoracic Oncology，the Cancer Hospital of University of Chinese Academy of Sciences(Zhejiang Cancer Hospital)，Chinese Academy of Sciences；The Innovation Institute for Artificial Intelligence in Medicine，Zhejiang University；Cancer Center of Zhejiang University）.The impact of lipids on the cancer—immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2023,第4期 Shuo Han^1,2，Xinru Chen¹，Leaf Huang¹（Division of Pharmacoengineering and Molecular Pharmaceutics，Eshelman School of Pharmacy，University of North Carolina at Chapel Hill；Department of Toxicology，Guangdong Provincial Key Laboratory of Tropical Disease Research，School of Public Health，Southern Medical University）.The tumor therapeutic potential of long non-coding RNA delivery and targeting[J].Acta Pharmaceutica Sinica B,2023,第4期 Yichen Zhong^1,2，Shi Du^1,2，Yizhou Dong^1,3,2（Division of Pharmaceutics & Pharmacology，College of Pharmacy，The Ohio State University；Icahn Genomics Institute，Precision Immunology Institute，Department of Oncological Sciences，Tisch Cancer Institute，Friedman Brain Institute，Icahn School of Medicine at Mount Sinai；Department of Radiation Oncology，Department of Biomedical Engineering，Center for Clinical and Translational Science，Comprehensive Cancer Center，Dorothy M. Davis Heart & Lung Research Institute，Center for Cancer Engineering，Center for Cancer Metabolism，Pelotonia Institute for Immune-Oncology，The Ohio State University）.mRNA delivery in cancer immunotherapy[J].Acta Pharmaceutica Sinica B,2023,第4期 Yang Liu¹，Wei Xu²，Mingxue Li¹，Yueying Yang¹，Dejuan Sun¹，Lidian Chen³，Hua Li^1,2，Lixia Chen¹（Wuya College of Innovation，Key Laboratory of Structure-Based Drug Design & Discovery，Ministry of Education，Shenyang Pharmaceutical University；Institute of Structural Pharmacology & TCM Chemical Biology，College of Pharmacy，Fujian University of Traditional Chinese Medicine；The Institute of Rehabilitation Industry，Fujian University of Traditional Chinese Medicine）.The regulatory mechanisms and inhibitors of isocitrate dehydrogenase 1 in cancer[J].Acta Pharmaceutica Sinica B,2023,第4期 Yuyu Liu，Xinnan Li，Songyang Sui，Jingshu Tang，Dawei Chen，Yuying Kang，Kebo Xie，Jimei Liu，Jiaqi Lan，Lei Wu，Ridao Chen，Ying Peng，Jungui Dai（State Key Laboratory of Bioactive Substance and Function of Natural Medicines，CAMS Key Laboratory of Enzyme and Biocatalysis of Natural Drugs，and NHC Key Laboratory of Biosynthesis of Natural Products，Institute of Materia Medica，Chinese Academy of Medical Sciences and Peking Union Medical College）.Structural diversification of bioactive bibenzyls through modular co-culture leading to the discovery of a novel neuroprotective agent[J].Acta Pharmaceutica Sinica B,2023,第4期 Changjun Lv¹，Minghui Sun²，Yilei Guo¹，Wenxin Xia¹，Simiao Qiao¹，Yu Tao¹，Yulai Fang¹，Qin Zhang¹，Yanrong Zhu¹，Yusufu Yalikun²，Yufeng Xia¹，Zhifeng Wei¹，Yue Dai¹（Department of Pharmacology of Chinese Materia Medica，School of Traditional Chinese Pharmacy，China Pharmaceutical University；Division of Sports Medicine and Adult Reconstructive Surgery，Department of Orthopedic Surgery，Nanjing Drum Tower Hospital，the Affiliated Hospital of Nanjing University Medical School）.Cholinergic dysfunction-induced insufficient activation of alpha7 nicotinic acetylcholine receptor drives the development of rheumatoid arthritis through promoting protein citrullination via the SP3/PAD4 pathway[J].Acta Pharmaceutica Sinica B,2023,第4期 Lu Su^1,2，Kellie S.Dalby¹，Hannah Luehmann³，Sussana A.Elkassih¹，Sangho Cho¹，Xun He¹，Lisa Detering³，Yen-Nan Lin¹，Nari Kang¹，Dennis A.Moore⁴，Richard Laforest³，Guorong Sun¹，Yongjian Liu³，Karen L.Wooley¹（Department of Chemistry，Department of Materials Science and Engineering，and Department of Chemical Engineering，Texas A&M University；Laboratory of Macromolecular and Organic Chemistry and Institute for Complex Molecular Systems，Eindhoven University of Technology；Mallinckrodt Institute of Radiology，Washington University School of Medicine；Bayer AG）.Ultrasmall, elementary and highly translational nanoparticle X-ray contrast media from amphiphilic iodinated statistical copolymers[J].Acta Pharmaceutica Sinica B,2023,第4期 Ramya Dhandapani，Swaminathan Sethuraman，Uma Maheswari Krishnan，Anuradha Subramanian（Centre for Nanotechnology ＆ Advanced Biomaterials，School of Chemical ＆ Biotechnology，SASTRA Deemed University）.Self-assembled multifunctional nanotheranostics against circulating tumor clusters in metastatic breast cancer[J].Acta Pharmaceutica Sinica B,2023,第4期 Shaowei Bing^1,2，Senfeng Xiang²，Zhimei Xia²，Yilong Wang^1,3，Zhonghai Guan^1,3，Jinxin Che^2,4，Aixiao Xu²，Xiaowu Dong^2,5,4，Ji Cao^2,5,4，Bo Yang²，Jinhu Wang^1,5,3，Qiaojun He^2,5,4，Meidan Ying^1,2,5,3（Department of Surgical Oncology，Children's Hospital，Zhejiang University School of Medicine；Institute of Pharmacology and Toxicology，Zhejiang Province Key Laboratory of Anti-Cancer Drug Research，College of Pharmaceutical Sciences，Zhejiang University；Pediatric Cancer Research Center，National Clinical Research Center for Child Health；Innovation Institute for Artificial Intelligence in Medicine，Zhejiang University；Cancer Center，Zhejiang University）.AKT inhibitor Hu7691 induces differentiation of neuroblastoma cells[J].Acta Pharmaceutica Sinica B,2023,第4期 Juan Pang¹，Jia Nuo Feng^2,3,4，Wenhua Ling¹，Tianru Jin^2,3,4（Division of Nutrition，School of Public Health，Sun Yat-sen University；Banting and Best Diabetes Centre，Faculty of Medicine，University of Toronto；Dept. of Physiology，University of Toronto；Division of Advanced Diagnostics，Toronto General Hospital Research Institute，University Health Network）.Commentary：Can FXR serve as a potential target for COVID-19 prevention?[J].Acta Pharmaceutica Sinica B,2023,第4期 Wei Tao（Center for Nanomedicine and Department of Anesthesiology，Brigham and Women’s Hospital，Harvard Medical School）.Editorial of Special Column on RNA Therapeutics and Drug Delivery Technologies for Medical Applications[J].Acta Pharmaceutica Sinica B,2023,第4期 Xiaoqing Fan，Chutian Mai，Ling Zuo²，Jumin Huang，Chun Xie^3,4,5，Zebo Jiang⁶，Runze Li⁷，Xiaojun Yao，Xingxing Fan，Qibiao Wu，Peiyu Yan，Liang Liu⁷，Jianxin Chen²，Ying Xie⁷，Elaine Lai-Han Leung^3,4,5（Dr.Neher’s Biophysics Laboratory for Innovative Drug Discovery，State Key Laboratory of Quality Research in Chinese Medicine，Macau University of Science and Technology；Beijing University of Chinese Medicine；Cancer Center；Faculty of Health Science；MOE Frontiers Science Center for Precision Oncology，University of Macau；Guangdong Provincial Key Laboratory of Biomedical Imaging and Guangdong Provincial Engineering Research Center of Molecular Imaging，the Fifth Affiliated Hospital，Sun Yat-sen University；State Key Laboratory of Dampness Syndrome of Chinese Medicine，the Second Affiliated Hospital of Guangzhou University of Chinese Medicine (Guangdong Provincial Hospital of Chinese Medicine)）.Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice[J].Acta Pharmaceutica Sinica B,2023,第3期 Tian-guang Zhang，Chao-yu Miao（Department of Pharmacology，Second Military Medical University/Naval Medical University）.Mitochondrial transplantation as a promising therapy for mitochondrial diseases[J].Acta Pharmaceutica Sinica B,2023,第3期 Mengnan Zhao¹，Rujing Wang¹，Kunmeng Yang²，Yuhong Jiang³，Yachen Peng^4,5，Yuke Li¹，Zhen Zhang¹，Jianxun Ding⁴，Sanjun Shi¹（State Key Laboratory of Southwestern Chinese Medicine Resources，School of Pharmacy，Chengdu University of Traditional Chinese Medicine；The First Norman Bethune College of Clinical Medicine，Jilin University；School of Life Science and Engineering，Southwest Jiaotong University；Key Laboratory of Polymer Ecomaterials，Changchun Institute of Applied Chemistry，Chinese Academy of Sciences；Department of Orthopedics，China-Japan Union Hospital of Jilin University）.Nucleic acid nanoassembly-enhanced RNA therapeutics and diagnosis[J].Acta Pharmaceutica Sinica B,2023,第3期 Lei Zhang^1,2,3，Biwei Ye^1,3，Zhuo Chen^1,2,3，Zhe-Sheng Chen（State Key Laboratory of Structural Chemistry，Fujian Institute of Research on the Structure of Matter，Chinese Academy of Sciences；University of Chinese Academy of Sciences；Fujian Agriculture and Forestry University；Department of Pharmaceutical Sciences，College of Pharmacy and Health Sciences，St.John’s University）.Progress in the studies on the molecular mechanisms associated with multidrug resistance in cancers[J].Acta Pharmaceutica Sinica B,2023,第3期 Sheng Chen^1,2，Tailin He²，Yiming Zhong²，Mingjue Chen²，Qing Yao²，Di Chen³，Zengwu Shao¹，Guozhi Xiao²（Department of Orthopaedics，Union Hospital，Tongji Medical College，Huazhong University of Science and Technology；Department of Biochemistry，School of Medicine，Shenzhen Key Laboratory of Cell Microenvironment，Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research，Southern University of Science and Technology；Research Center for Human Tissues and Organs Degeneration，Shenzhen Institutes of Advanced Technology，Chinese Academy of Sciences）.Roles of focal adhesion proteins in skeleton and diseases[J].Acta Pharmaceutica Sinica B,2023,第3期 Mengyao Hao¹，Rong Fu¹，Jun Tai，Zhenhuan Tian³，Xia Yuan⁴，Yang Chen⁵，Mingjin Wang¹，Huimin Jiang¹，Ming Ji¹，Fangfang Lai¹，Nina Xue¹，Liping Bai⁶，Yizhun Zhu⁶，Xiaoxi Lv¹，Xiaoguang Chen¹，Jing Jin¹（State Key Laboratory of Bioactive Substances and Functions of Natural Medicines，Institute of Materia Medica，Chinese Academy of Medical Sciences，Peking Union Medical College；Department of Otolaryngology，Head and Neck Surgery，Children’s Hospital Capital Institute of Pediatrics；Department of Thoracic Surgery，Peking Union Medical College Hospital，Peking Union Medical College；State Key Laboratory of Natural and Biomimetic Drugs，School of Pharmaceutical Sciences，Peking University；Department of Pharmacology，School of Pharmaceutical，Guangzhou University of Chinese Medicine；State Key Laboratory of Quality Research in Chinese Medicine，Macau Institute for Applied Research in Medicine and Health，Macau University of Science and Technology）.S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung[J].Acta Pharmaceutica Sinica B,2023,第3期首页上一页 6 7 8 9 10 下一页尾页共有11页，转到页

期刊文章列表